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The goal of this series of experiments was to develop an operant choice procedure to examine rapidly
the punishing effects of intravenous drugs in rats. First, the cardiovascular effects of experimenter-
administered intravenous histamine, a known aversive drug, were assessed to determine a biologically
active dose range. Next, rats responded on each of two levers with concurrently available fixed-ratio 1
schedules of food reinforcement. Intravenous histamine was delivered along with food when responses
were made on one of the options, and the lever on which both food and histamine were contingent was
switched on a regular basis. A dose of 1.0 mg/kg/inj of histamine was effective in moving responding to
the alternate lever, whereas saline, 0.1, or 0.3 mg/kg/inj of histamine were not. Histamine injections
produced reliable selection of the alternate lever when they were presented on the same lever for three
consecutive sessions, but not when they were switched between levers on each session. In addition,
histamine produced greater selection of the alternate lever when it was presented with shorter intertrial
interval durations. These findings indicate that, with appropriate parameters, the aversive effects of
histamine and perhaps other drugs can be established rapidly using a concurrent choice procedure.
Key words: choice, punishment, aversive stimuli, acquisition, reversal learning, histamine, rat, lever
press
_______________________________________________________________________________
A limitation of standard drug self-adminis-
tration procedures is that only two outcomes
are possible: drugs either function as reinforc-
ers or they do not. If an animal does not self-
administer a drug, this could be because the
drug is behaviorally inactive or because the
drug is aversive. Because both effects are
reflected by the same pattern of little or no
self-administration, the standard self-adminis-
tration procedure does not readily allow one
to make a distinction between inactive and
aversive drug effects. The ability to character-
ize aversive properties of drugs is important to
understand more completely how drugs im-
pact behavior. Yet, compared with our sub-
stantial understanding of the reinforcing
effects of drugs, relatively little is known about
how aversive drugs impact behavior.
One approach for examining the aversive
effects of drugs has been to assess the
punishing effects of response-contingent in-
travenous drugs on steady-state operant behav-
ior. In one procedure using squirrel monkeys,
food reinforcement was available on fixed-
ratio (FR) 30 schedules in two components of
a multiple schedule and a drug was injected
contingent on responding in one component
(e.g., Katz & Goldberg, 1986; Goldberg, 1980;
Goldberg & Spealman, 1983; Takada, Barrett,
Allen, Cook, & Katz, 1992). For instance, Katz
and Goldberg found that responding was
suppressed only in the drug component when
the first response following food reinforce-
ment resulted in an injection of histamine.
Katz and Goldberg found that the suppression
of responding by histamine was dose depen-
dent in a pattern similar to that found when
different intensities of shock were presented.
Choice procedures have considerable po-
tential for evaluating the aversive effects of
drugs. Unlike other models used to infer
aversive drug effects with response-indepen-
dent drug injections (e.g., place condition-
ing), operant choice procedures have few
interpretive problems with respect to under-
standing the relation between behavior and
drug (see Bardo & Bevins, 2000, for a
discussion). In addition, the response-decreas-
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ing effects of shock punishment have been
shown to be more effective in choice proce-
dures than when simple schedules are used.
For instance, Azrin and Holz (1966) found
that a response resulting in both food and
shock decreased much faster and more com-
pletely when an alternative ‘‘nonpunished’’
response was available (see also Herman &
Azrin, 1964; Holz, Azrin, & Ayllon, 1963;
Karsh, 1971; Rachlin, 1967). Woolverton
(2003) developed a choice procedure to study
the aversive effects of drugs on steady-state
behavior. Responding was maintained on two
concurrently available variable-ratio (VR) 10
schedules of food reinforcement in rhesus
monkeys; histamine injections were introduced
contingent on left or right lever responses
across conditions. Woolverton found relatively
less responding on the lever producing food
plus histamine across a range of histamine
doses (0.0015 – 0.006 mg/kg/inj). This
suggests that the aversive effects of intrave-
nous drugs can be examined through their
selective punishing effects on operant choice
behavior.
The overarching goal of the present series of
experiments was to develop an operant choice
procedure with rats that could rapidly assess
the aversive effects of drugs. In the present
series of experiments, rats with intravenous
indwelling catheters responded on two con-
currently available FR 1 schedules of food
reinforcement. Responding on one lever also
produced an intravenous injection of hista-
mine. Histamine is an endogenous neuro-
transmitter involved in itch and inflammation
(see Hough, 2001) and has punishing effects
as described above (e.g., Katz & Goldberg,
1986). As in Woolverton (2003), a punishing
effect of histamine was indicated if fewer
responses occurred on the lever producing
both food and histamine than on the lever
producing food alone. In addition, the non-
histamine lever was used to indicate whether
the direct effects of histamine suppressed
behavior in general or functioned primarily
as a punisher (i.e., were selective to the
histamine-contingent lever).
EXPERIMENT 1
The range of active histamine doses in rats
has not been thoroughly evaluated. In re-
strained squirrel monkeys, Goldberg (1980)
found that intravenous histamine injections
increased heart rate and decreased blood
pressure at doses that produced punishing
effects (0.03 – 0.3 mg/kg/injection). We
therefore assumed that doses producing
strong cardiovascular effects would also pro-
duce punishing effects and initially deter-
mined a range of histamine doses that
produced cardiovascular effects in rats.
METHOD
Subjects
Ten male Sprague-Dawley rats obtained
from Harlan (Indianapolis, IN), weighing
approximately 300 g before experimentation,
were maintained in a temperature- and hu-
midity-controlled environment on a 12-h
light/dark cycle with lights on at 7:00 a.m.
Standard laboratory chow and water were
provided freely throughout the experiment.
All studies were carried out in accordance with
the Guide for Care and Use of Laboratory Animals
as adopted by the National Institutes of
Health. University of Michigan’s Committee
on the Use and Care of Animals approved all
experimental protocols.
Surgery: cardiovascular study. Four rats were
anesthetized with ketamine (100 mg/kg i.m.)
and xylazine (10 mg/kg i.m.). The femoral
vein and artery were exposed with a longitu-
dinal incision. A catheter of Micro-Renathane
tubing (Braintree Scientific, Inc., Braintree,
MA) was inserted into the vein and the
pressure sensor tip of the telemetry device
(Data Sciences International, St. Paul, MN)
was inserted into the artery. The telemetry
device was placed subcutaneously by the hind
leg. The distal end of the intravenous catheter
was run subcutaneously and exited through
the back, where it was secured. The distal end
of the catheter was covered with a metal
obturator when not in use. Rats were given a
week to recover from surgery, during which
time catheters were flushed daily with saline.
Surgery: behavioral study. Six rats were surgi-
cally implanted with chronic indwelling cath-
eters. Rats were anesthetized with ketamine
(100 mg/kg i.m.) and xylazine (10 mg/kg
i.m.) before a longitudinal incision was made
to expose the femoral vein into which a
catheter made of Micro-Renathane tubing
was inserted. This tubing was connected to a
metal cannula attached to a mesh backplate
that was secured subcutaneously. The metal
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cannula exited the skin and connected to a
plastic cap. Catheters were flushed daily with
saline to maintain patency.
Apparatus
Cardiovascular equipment. Implantable telem-
etry devices (PA-C40) and receivers (RPC-1)
were used for recording heart rate and blood
pressure (Data Sciences International, St. Paul,
MN). Data recording was conducted with
DataQuestART (Data Sciences International,
St. Paul, MN).
Operant chamber. Six Med AssociatesH (St.
Albans, VT, USA) operant conditioning cham-
bers were used. Each chamber was approxi-
mately 30 cm long, 24 cm wide, and 21 cm
high, and housed in a sound-attenuating
cubicle. The front panel of each chamber
was equipped with two retractable response
levers 6.8 cm above the grid floor and 1.3 cm
from the side walls with a horizontal array of
red, yellow, and green LEDs above each lever.
A 28-V DC houselight was located at the top
center of the opposite panel. Between the two
levers was a pellet receptacle with its bottom
edge 2 cm above a grid floor in which 45-mg
sucrose pellets (Bio-Serv, Frenchtown, NJ)
could be presented. Injections were delivered
silently through i.v. catheters attached to a
tether joined by a swivel to a syringe pump
(MED Associates, St. Albans, VT) located
outside of the sound attenuating cubicle. A
chamber ventilation fan masked extraneous
noise. Therefore, it is unlikely the rats could
hear injections. Injection duration was based
on weight (g) of each rat divided by drug-
delivery pump flow rate (0.0722 ml per s),
yielding an injection of 4.16 s for a 300-g rat.
Swivels were held in place by a counterbal-
anced arm (MED Associates). Control of
experimental events and data recording were
conducted with Med Associates interfacing
and programming.
Cardiovascular Procedure
Rats were placed in a covered PlexiglasH
cage (28 cm long 3 19 cm wide 3 20 cm high)
with corncob bedding. The distal end of the
catheter, which exited through the rat’s back,
was connected to a tether that exited from the
top of the cage. The end of the tether was
connected to a 1.0 ml syringe used to inject
drugs. For experimental sessions, telemetry
devices were activated and cages were placed
on top of the receivers; recording began when
the cage was placed on the receiver. Approx-
imately 30 min after data recording began, a
saline injection (0.8 ml, i.v.) was delivered.
After approximately 20 min, histamine injec-
tions were delivered in the following order:
0.01, 0.03, 0.1, 0.3, 1.0, 0.1 mg/kg/inj. Each
histamine injection was immediately followed
by a saline flush (0.5 ml). Histamine injections
were separated by at least 20 min. Injections
were 1 ml per kg injected across 5 s. Data was
sampled every 10 s and collection lasted
approximately 5 hr.
Behavioral Procedure
Preliminary training. Rats were provided with
a dish of sucrose pellets in their home cage
across successive days until all rats consumed
the pellets (1 or 2 days). Next, rats were placed
in the operant chamber with the houselight on
and pellets were delivered response indepen-
dently on a random-time (RT) 60-s schedule.
Under all conditions, the houselight was
turned off for 0.25-s during each pellet
presentation. During the next two sessions,
rats were trained to respond on the levers
using a modified autoshaping procedure (see
Brown & Jenkins, 1968; Peterson, Ackil,
Frommer, & Hearst, 1972). A trial began when
one lever was randomly chosen and extended
into the chamber and the LEDs over the lever
were illuminated. If the lever was pressed
within 8 s, the lever was retracted, LEDs
turned off, and a pellet was presented. If no
response occurred, the lever was retracted,
LEDs turned off, and a pellet was presented
following 8 s from trial onset. Intertrial
intervals (ITIs) were 60 s in duration (time
between end of sucrose-pellet presentation
and lever extension). Sessions remained in
effect for 1 hr.
In the final training session, rats were
presented with both levers extended and LEDs
turned on above both levers. A response on
either lever produced a food pellet and both
levers were retracted and LEDs turned off. If
no response occurred within 60 s, both levers
were retracted and LEDs turned off. Trials
were initiated 5 s after the levers were retracted
on the previous trial (i.e., 5-s ITI). All sessions
were initiated with two forced-choice trials in
which one lever was randomly selected and
extended into the chamber. A response
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produced a food pellet and the same stimuli
and ITI as described. Sessions remained in
effect for 1 hr or until 100 trials were
completed (including the initial forced-choice
trials). Rats were surgically catheterized follow-
ing the final training session and given one
week to recover.
Baseline condition. The baseline condition
was identical to the final session of the
preliminary sucrose-pellet training with an
exception. Following a response on one lever,
an intravenous injection accompanied the
sucrose-pellet presentation in both forced-
choice and standard trials. A response on the
other lever produced only a sucrose pellet.
Histamine injections were contingent on
responses on the lever on which a majority of
responses occurred during the last sucrose-
training session. Condition changes typically
occurred following three sessions, although
occasionally four sessions were arranged when
no differential responding was present across
levers. Upon changes in condition, all injec-
tions were made contingent on the lever with a
greater number of responses in the last session
of the previous condition. For instance, if
1.0 mg/kg/inj dose of histamine decreased
left-lever responding more than right-lever
responding and the dose was changed to
0.3 mg/kg/inj, the new dose would be made
contingent on right-lever responses.
Drugs. Histamine hydrochloride (Sigma
Chemical Co., St. Louis, MO) was dissolved
in 0.9% saline solution. Doses of histamine are
expressed as weights of the salt.
RESULTS
All statistical tests used an alpha set at .05.
Cardiovascular Effects
Figure 1 shows the peak effects of histamine
on heart rate and blood pressure. Heart rate
increased (top-left panel) while systolic and
diastolic blood pressure decreased (top-right
panel) with increases in histamine dose. These
findings were supported by one-way repeated-
measures analysis of variance (ANOVA) show-
ing significant increases in heart rate, F(5, 30)
5 16.42, and decreases in systolic, F(5, 30) 5
Fig. 1. The top-left panel shows mean (6SEM) peak effect of heart rate as beats per min (BPM) as a function of i.v.
saline vehicle (V) and histamine dose (mg/kg/inj). The top-right panel shows mean (6SEM) peak effect of systolic and
diastolic blood pressure as millimeters of mercury (mmHg) as a function of i.v. saline vehicle and histamine dose.
Triangle symbols indicate replications of the 0.1 mg/kg/inj dose. * 5 significantly different from vehicle (p , .05). The
bottom-left panel shows real-time measurement of blood pressure (BP) and heart rate (HR) with i.v. saline vehicle and
different doses of histamine in a representative rat. The bottom-right panel shows the effect of the 1.0 mg/kg/inj dose of
histamine in greater detail. The histamine injection occurred immediately prior to onset of effects.
206 CHRISTOPHER A. PODLESNIK et al.
135.50, and diastolic, F(5, 30) 5 119.40, blood
pressure. Bonferroni post hoc analyses show
that all three cardiovascular measures differed
from vehicle at all doses except 0.01 mg/kg/
inj. Replication of the 0.1 mg/kg/inj hista-
mine (triangle symbols) produced results that
fell within range of the initial injection of that
dose for all cardiovascular measures.
The bottom panel of Figure 1 shows data
from a representative rat in which blood
pressure and heart rate were assessed. The
size of effect on blood pressure and heart rate
increased with increasing histamine dose. In
addition, the duration of action also increases
with larger doses. Onset of changes in these
cardiovascular measures occurred approxi-
mately 5 s following all histamine doses
(detailed data not shown). The x-axis for the
1.0 mg/kg/inj dose of histamine is expanded
and shown in the right-bottom panel. Heart
rate remained elevated for over 10 min while
changes in blood pressure approached base-
line levels after about 2.5 min. Given that the
1.0 mg/kg/inj dose reliably affected cardio-
vascular measures, the 1.0 mg/kg/inj dose was
used as the starting dose in the choice
procedure.
Behavioral Effects
Figure 2 shows the number of responses on
the sucrose + injection and sucrose-alone
levers in all 60-min sessions. Note that the
graphs for Rats G2 and G3 are both in the
second row. Conditions in which the injection
was switched from one lever to the other are
noted by adding ‘‘+Sw’’ to the injected dose or
solution on the condition labels (e.g., sa-
line+Sw). During training (T) with sucrose
pellets on both levers, rats responded on both
levers. In the next session, 1.0 mg/kg/inj
histamine was introduced on the preferred
lever. For all rats, responses on the sucrose +
injection lever decreased relative to responses
on the sucrose-alone lever and, with the
exception of Rat G2, responses increased on
the sucrose-alone lever. When the sucrose +
injection lever was switched for Rats G2 to G5,
responding on that lever was lower than on the
sucrose lever by the third histamine session for
all rats.
Responding on both levers was suppressed
to varying degrees across rats in the first
1.0 mg/kg/inj histamine condition for Rats
G1 and G2 and following the switch in sucrose
+ injection lever for Rats G2, G4, and G5.
Thus, responding sometimes was low on both
levers and not just the lever producing
intravenous injections of histamine.
In the following conditions, histamine was
removed by turning off the infusion pump (no
inj) and/or by injecting saline. Black data
points in the No Injection conditions indicate
the sucrose + injection lever in the previous
condition. The pattern of responding tended
to continue under both of these conditions,
suggesting a conditioned punishing effect,
with the exception of the saline condition for
Rat G3, in which responding was not system-
atic across sessions. Shortly after the saline
condition, Rat G2 irreparably lost its catheter.
Following saline injections and at various
points throughout the experiment, 1.0 mg/
kg/inj of histamine was reintroduced and
responding consistently decreased on the
sucrose + injection lever and increased on
the sucrose-alone lever.
When the dose was decreased to 0.3 mg/kg/
inj for all rats, the effects were mixed.
Responding on the sucrose + injection lever
decreased below the sucrose lever for Rats G3
and G5. Responding on the sucrose + injection
lever did not decrease below the sucrose lever
in the first determinations for Rats G1, G4, or
G6 but did in later determinations for Rats G1
and G6. The 0.1 mg/kg/inj dose did not
systematically decrease responding for any rat
tested at that dose (i.e., G1, G4, and G5). The
patterns of responding with the 0.1 mg/kg/inj
dose resembled those found during the Saline
or No Injection conditions.
Figure 3 shows the effects of histamine dose
as percent sucrose + injection-lever responses
across the 6 rats in the choice procedure. Each
data point is the mean of the last session of a
condition for all determinations of a condition
for all rats. No Injection and Saline sessions
are combined under 0 mg/kg/inj on the x-
axis. In general, the percentage of responding
on the sucrose + injection lever decreased with
increasing dose, which is supported by a
significant main effect of dose, F(3, 40) 5
7.17, using a repeated-measures ANOVA.
Bonferroni post hoc comparisons show that
the 1.0 mg/kg/inj dose is the only dose that
differed significantly from the 0 mg/kg/inj.
To provide a better picture of how hista-
mine injections impacted choice responding
within and across sessions, Figure 4 shows
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within-session responding in the three sessions
of the first condition with 1.0 mg/kg/inj of
histamine as a function of time in session.
Successive responses on the sucrose + injection
and sucrose-alone lever are connected by the
line. Thus, the line aids in observing time
between responses and switches between le-
vers. Reinforcement and ITI times are includ-
ed. Session duration tended to decrease from
Session 1 to Sessions 2 and 3, as indicated by
data terminating farther to the left along the x-
axis across sessions. This finding is supported
by a one-way repeated-measures ANOVA, F(2,
10) 5 8.57, with Bonferroni post hoc analyses
showing that Sessions 2 and 3 differed from
Session 1 but not from each other.
Figure 4 also shows that the pattern of
responding on the two levers changed across
sessions. In Session 1, responses on the sucrose
+ injection lever were interspersed throughout
the session. In Sessions 2 and 3, conversely,
most sucrose + injection responses tended to
Fig. 2. Number of responses on the sucrose + injection (inj) lever and sucrose lever across preliminary sucrose-pellet
training (T) and various doses of histamine (mg/kg/inj), saline vehicle, and no injections (no inj). Individual panels
show data of individual rats (G1-G6). Lever switches (when the consequences are reversed) are indicated by ‘‘Sw.’’
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occur more towards the beginning of the
session (except for Rat G2). Given that session
duration decreased, it is not entirely clear
from Figure 4 whether the distribution of
sucrose + injection responses changed or
whether the shorter sessions produce this
impression. To best convey this effect, the
time of the last sucrose + injection and
sucrose-alone responses were normalized as a
function of total session time. Thus, if the last
response occurred 30 min into a 60-min
session, that response would be coded as
50%. The last response on both the sucrose
+ injection lever and the sucrose-alone lever
similarly occurred toward the end of the
session during Session 1. Across Sessions 2
and 3, the last response on the sucrose-alone
lever continued to occur toward the end of
those sessions, whereas the last response on
the sucrose + injection lever tended to occur
more toward the beginning of those sessions.
A two-way repeated-measures ANOVA (lever x
Fig. 3. The percent responses on the sucrose + injection lever as a function of dose of i.v. histamine (mg/kg/inj). In
the panel showing mean data, there are 11 values at 0 mg/kg/inj, 3 values at 0.1 mg/kg/inj, 9 values at 0.3 mg/kg/inj,
and 21 values at 1.0 mg/kg/inj. * 5 significantly different from 0 (p , .05).
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session) confirmed a significant effect of lever,
F(1, 14) 5 25.98, and session, F(2, 14) 5 9.71,
but not a lever x session interaction, F(2, 14) 5
14.75. Bonferroni post hoc analyses show
that lever differed significantly only during
Session 3.
Another pattern apparent from Figure 4 is
that latency to respond on either lever appears
to be longer following responses on the
sucrose + injection lever than following re-
sponses on the sucrose-alone lever. This was
assessed by examining response speed (1/
latency [s]) as a function of session. Although
the effect was not large, response speed
tended to be faster on the sucrose-alone lever.
Using a repeated-measures ANOVA (lever x
Fig. 4. Within-session pattern of responding across the first three sessions of the first condition of 1.0 mg/kg/inj
dose of histamine as a function of time (min) in the session.
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session), this effect was supported by a
significant main effect of lever, F(1, 14) 5
10.84, but not session, F(2, 14) 5 13.78, nor
their interaction, F(2, 14) 5 2.44. Thus,
injections of histamine decreased both overall
responses on that lever and increased the time
to make the next response.
DISCUSSION
The present experiment showed that, when
sucrose pellets maintained rats’ responding on
two concurrently available responses, present-
ing intravenous injections of histamine con-
tingent on one response decreased that
response. Therefore, the findings from the
present experiment resemble other studies
with primates showing that intravenous hista-
mine is an effective punisher of operant
behavior (e.g., Katz & Goldberg, 1986; Gold-
berg, 1980; Goldberg & Spealman, 1983;
Takada et al., 1992; Woolverton, 2003) and
extend those findings to a concurrent sched-
ule in rats. Importantly, experimental control
over histamine’s punishing effects was demon-
strated when switching the response in which
histamine injections were contingent resulted
in a corresponding change in responding. In
addition, control over the punishing effects of
histamine could be established rapidly—within
three sessions of exposure to histamine injec-
tions. Therefore, the present procedure pro-
vides a rapid method for examining the
punishing effects of an intravenous drug on
choice behavior by rats.
In addition to simply decreasing the num-
ber of responses on the lever producing
histamine, the speed of producing another
response decreased and overall responding on
both levers occasionally tended to decrease as
well. One possibility is that these decreases are
a result of the direct pharmacological effects
of histamine. However, Katz and Goldberg
(1986) found longer pauses (decreased re-
sponse speed) on a histamine lever even
before the first response produced a histamine
injection. In addition, when responses on the
histamine lever were selectively suppressed,
responding on the lever presenting only
sucrose often occurred at maximal levels.
Finally, both decreases in response speed
(e.g., Dardano & Sauerbrunn, 1964) and
overall responding (Bolles, Holtz, Dunn, &
Hill, 1980; Karsh, 1970) have been shown with
punishment by electric shock and, therefore,
these effects are more likely attributable to
a response-suppressing effect of punishing
stimuli.
The doses required to produce punishing
effects with histamine in the present experi-
ment (i.e., 0.3 - 1.0 mg/kg/inj) were higher
than those needed in previous studies with
monkeys (e.g., Goldberg, 1980; Katz & Gold-
berg, 1986; Woolverton, 2003). It is unclear
whether the differences in potency of hista-
mine are a result of species and/or procedural
differences, although choice procedures typi-
cally have been more sensitive than simple
schedules for detecting punishing effects of
stimuli (e.g., Azrin & Holz, 1966). Relatively
small procedural differences have been shown
to impact the potency of histamine on the
responding of squirrel monkeys on multiple
schedules. For instance, Goldberg found pun-
ishing effects of histamine doses ranging from
0.03 to 0.1 mg/kg/inj when the 11th and 22nd
response after FR-30 food reinforcement
resulted in histamine injections, but Katz and
Goldberg found that slightly larger doses at 0.1
and 0.3 mg/kg/inj were required to achieve
punishing effects when only the first response
after food reinforcement resulted in a hista-
mine injection. Perhaps further suggesting
that procedure modulates the behavioral
effects of histamine, the same doses (0.03 –
1.0 mg/kg/inj) produced cardiovascular ef-
fects in both the present experiment with rats
and Goldberg’s cardiovascular studies with
squirrel monkeys. Although likely, at this point
it is unclear whether rats are less sensitive to
histamine than primates.
Another potentially important difference
between the present procedure and those
used by Goldberg and colleagues (e.g., Gold-
berg, 1980; Katz & Goldberg, 1986) is that, in
their procedure, histamine injections were
always signaled by a distinct stimulus change
(i.e., light change). Perhaps the light change
took on conditioned aversive properties of its
own when paired with histamine and en-
hanced that effect (see Hake & Azrin, 1965,
for related findings). In fact, Katz and Gold-
berg found that response rates often did not
return to control levels when saline was
substituted for histamine injections. Such
stimuli are not necessary to observe punishing
effects of low doses of histamine, however.
Using a choice procedure with food and
intravenous histamine or saline across two
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response alternatives, Woolverton (2003)
found punishing effects of histamine in rhesus
monkeys at even smaller doses (0.0015 –
0.006 mg/kg/inj) than Goldberg and col-
leagues, but without pairing histamine injec-
tions with a stimulus change distinct from
saline injections.
Although the dose needed to produce a
punishing effect in the present experiment
was larger than those in other experiments,
this might have been a result of our allowing
only three sessions per condition. If respond-
ing were allowed to continue to stability, as was
the case in the other experiments examining
the punishing effects of histamine (e.g., Katz &
Goldberg, 1986; Goldberg, 1980; Goldberg &
Spealman, 1983; Takada et al., 1983; Woolver-
ton, 2003), smaller doses might have punished
responding as well. Support for this supposi-
tion lies in the fact that the 0.3 mg/kg/inj
dose of histamine produced a punishing effect
only in a second exposure to that dose for Rats
G1 and G6. Thus, more extensive experimen-
tal experience might have increased the rats’
sensitivity to the punishing effects of histamine
in this procedure. The mechanism for this
increased sensitivity, whether it be behavioral,
pharmacological, or both, is unclear. None-
theless, the findings from the present exper-
iment show that the aversive effects of intrave-
nous histamine can be examined as a punisher
in an operant choice procedure in rats.
EXPERIMENT 2
Experiment 2 attempted to assess whether
the punishing effects of 1.0 mg/kg of hista-
mine could be examined even more rapidly
than in Experiment 1 by switching the sucrose
+ injection and sucrose-alone levers across
daily experimental sessions. If performance
was sensitive to session-by-session changes,
experimental manipulations (e.g., dose-effect




Six male Sprague-Dawley rats were obtained
and maintained in the same manner as those
used in the behavioral experiment in Experi-
ment 1. The operant chambers also were the
same as those used in Experiment 1.
Procedure
Preliminary training with sucrose pellets was
the same as in Experiment 1. After training, two
conditions of three sessions were arranged with
1.0 mg/kg/inj histamine. Next, the sucrose +
injection lever was switched across several daily
sessions. Two more conditions then were
arranged with the sucrose + injection lever
maintained for three consecutive sessions.
Finally, for the surviving rats, daily switches of
the sucrose + injection lever were arranged.
RESULTS
Figure 5 shows the number of responses on
the sucrose + injection and sucrose-alone
levers, and the percentage of responses on
the sucrose + injection lever. When three
sessions per condition were arranged, re-
sponding resembled patterns seen with the
1.0 mg/kg/inj dose in Experiment 1. Howev-
er, performance varied across rats with daily
switches. Some rats consistently responded
more on the sucrose-alone lever (e.g., P1)
whereas others alternated between responding
more on the sucrose-alone lever and suppres-
sion on both levers (e.g., P4). Interestingly,
this alternating pattern during initial daily
switches could be predicted by comparing the
amount of suppression in the two conditions
prior to daily switches. In the final condition of
daily switches following additional training
with three-session conditions, performance
continued to vary across rats but not necessar-
ily in the same pattern as during initial daily
switches (e.g., P3 & P6).
DISCUSSION
As in Experiment 1, 1.0 mg/kg/inj hista-
mine punished responding when examined
across three-session conditions. However, per-
formance varied under daily lever switches and
showed no clear signs of improvement either
with additional daily lever switches or follow-
ing additional three-session conditions. Rela-
tive response rates in operant choice situations
have been shown to be sensitive to daily or
within-session changes in both reinforcement
(Davison & Baum, 2000; Mazur, 1992; Mazur &
Ratti, 1991) and punishment contingencies
(e.g., Karsh, 1970). It is possible that rats
would begin to switch reliably given more
training with daily switches. The goal of the
present experiment, however, was not to
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determine the amount of training needed to
reach such performance but simply to deter-
mine whether daily switches with drug punish-
ment could be used as a tool for more rapid
assessment of drug effects. At least with these
specific procedures, the present experiment
suggests they cannot.
EXPERIMENT 3
Experiments 1 and 2 showed that intrave-
nous injections of 1.0 mg/kg of histamine
function as a reliable punisher of operant
choice behavior in rats and that multiple
sessions are important for the punishment
effect to be demonstrated reliably. The goal of
Experiment 3 was to assess how the punishing
effects of the 1.0 mg/kg/inj of histamine can
be modified by changes to the temporal
context. One such manipulation that has been
shown to impact behavior in a variety of
Pavlovian and operant procedures is changing
the time between trials (i.e., massed vs. spaced
trials). Generally speaking, longer ITIs tend to
increase or enhance performance in both
Pavlovian (e.g., Gibbon, Baldock, Locurto,
Gold, & Terrace, 1977) and operant tasks
(e.g., Grant, 1975). Across conditions of the
present experiment, the duration of the ITI
varied from 6 s to 120 s.
Fig. 5. Number of responses on the sucrose + injection (inj) lever, sucrose lever, and percent responses on the
injection lever across preliminary sucrose-pellet training (T), three-session conditions, and conditions with daily
switching of the sucrose + injection lever. Individual panels show data of individual rats (P1-P6). Lever switches are
indicated by ‘‘Sw.’’
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METHOD
Subjects and Apparatus
Five male Sprague-Dawley rats were ob-
tained and maintained in the same manner
as those used in the behavioral experiments in
Experiments 1 and 2. The operant chambers
also were the same as those used in Experi-
ments 1 and 2.
Procedure
The training and baseline procedures were
identical to those used in Experiments 1 and 2,
except for differences in ITI duration during
preliminary training with concurrent FR 1
schedules of sucrose-pellet delivery and follow-
ing the introduction of 1.0 mg/kg/inj of
histamine. For Rats B1, B2, and B3, the ITI
duration was 120 s with a maximum session
time of 60 min. Thus, rats could complete a
total of approximately 30 trials (including
forced-choice trials) in a session. For Rats B4
and B5, the ITI duration was 30 s with a
maximum session time of 60 min. If sufficient-
ly high rates of trial completion occurred, 100
trials (including forced-choice trials) could be
completed in a session. Following 3-4 sessions
per condition, ITI durations were changed
across conditions with or without a switch in
the sucrose + injection lever. The ITI values
investigated were 6 s, 30 s, 60 s, 90 s, and 120 s.
All ITI values were timed from lever press and
the retraction of the levers to the beginning of
the next trial (in which the levers were
reintroduced into the chamber).
RESULTS
Figure 6 shows individual rats’ responding in
the choice procedure as number of sucrose +
injection responses, sucrose-alone responses,
Fig. 6. Number of responses on the sucrose + injection (inj) lever, sucrose lever, and percent responses on the
injection lever across preliminary sucrose-pellet training (T) and various ITI durations. Individual panels show data of
individual rats (B1-B5). Lever switches are indicated by ‘‘Sw.’’
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and percent histamine lever responding. For
rats beginning with a 120-s ITI (Rats B1, B2, and
B3), responding was similar across the two levers
for Rat B1, and higher on the sucrose +
injection lever for Rats B2 and B3. Thus, with
120-s ITIs, histamine injections did not function
as a punisher. With 30-s ITIs, all rats responded
more on the sucrose-alone lever. Switching the
histamine injection to the other lever produced
a switch in responding for all rats. Returning to
the 120-s ITI while keeping histamine injections
contingent on the same lever resulted in no
systematic effect for Rat B1 but fewer responses
on the sucrose + injection lever for Rat B2.
Next, the histamine lever was switched and
ITI duration was changed to 6 s for all rats, as
indicated by the thick, vertical condition-
change line on each panel, except for Rat B3
whose ITI remained at 30 s. The ITI duration
was increased across conditions to 120 s for all
rats with no change in histamine lever. As can
be seen, responding was reliably lower on the
sucrose + injection lever at each condition.
When the histamine lever switched for Rats B2,
B3, B4, and B5 at the 120-s ITI, as indicated by
the thick and vertical dash-dotted lines, in no
case did responding reliably decrease on the
sucrose + injection lever. Thus, low levels of
responding on the sucrose + injection lever
with increases in ITI but without lever switches
in the previous conditions likely were a
function of a sustained pattern of responding
from when ITI duration was shorter. For Rats
B2 and B4, ITI duration was decreased with a
switch in histamine lever across conditions.
Although responding was not lower on the
sucrose + injection lever at 90-s or 60-s ITIs,
responding was reliably decreased on the
sucrose + injection lever when returned to
the 6-s ITI.
Figure 7 shows percent responding on the
sucrose + injection lever as a function of ITI
duration across all conditions and all rats. In
general, the percentage of responding on the
sucrose + injection lever increased with longer
ITIs. Using a repeated-measures ANOVA,
percent responding on the sucrose + injection
lever was significantly increased with increas-
ing ITI, F(4, 38) 5 6.00. Bonferroni post hoc
comparisons show that the 90-s and 120-s ITIs
differed from the 6-s ITI. Overall, these
findings suggest that shorter ITIs of 6 or 30 s
resulted in a smaller proportion of responses
allocated to the sucrose + injection lever than
when longer ITIs of 60, 90, or 120 s were in
effect.
DISCUSSION
The findings from Experiment 3 suggest
that the punishing effect of histamine is
attenuated with longer ITIs. However, the
duration of the session was maintained at a
maximum of 60 min regardless of ITI dura-
tion. Thus, when ITI duration is long, there
were fewer possible trials per session. Instead
of 98 trials, only 28 trials could be completed
in the 60-min session. Therefore, instead of
the increased responding on the histamine
lever being a function of ITI duration,
performance might have been a result of
fewer trials.
One pattern from the present experiment
suggests that ITI duration might have directly
impacted performance. Although not statisti-
cally significant, there was a tendency for
histamine responding to be greater during
sessions with 30-s ITIs compared to 6-s ITIs.
This finding is potentially meaningful because
98 trials could be completed with both these
ITI durations within the 60-min session. This
finding was supported by an unpaired t test on
the mean number of trials per condition
across all conditions and rats, t(12) 5 1.261,
n.s. Thus, the present findings suggest that the
punishing effects of histamine decreased with
longer ITIs.
EXPERIMENT 4
Experiment 4 held the number of trials per
session constant with different groups of rats
receiving short versus long ITIs. In addition,
conditions continued until clear patterns of
performance were established during condi-
tions of both acquisition and reversal learning
(i.e., lever switch). One group had a short ITI
(5 s) with 28 possible trials per session; the
other group had a long ITI (120 s) with 28
possible trials per session. If longer ITI
durations disrupt performance, as suggested
by the findings of Experiment 3, acquisition
should be faster in the group with short ITIs.
In addition, the effects of a change in the
sucrose + injection lever were assessed follow-
ing acquisition. A large body of literature
suggests that conditions facilitating acquisition
do not necessarily facilitate reversals in learn-
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Twelve male Sprague-Dawley rats were ob-
tained and maintained in the same manner as
those used in the choice procedures of
Experiments 1, 2, and 3. The operant cham-
bers also were the same as those used in
Experiments 1, 2, and 3.
Procedure
The procedures were similar to those used
in Experiments 1, 2, and 3. Preliminary
training was identical to that described in
Experiments 1 and 2 with 5-s ITIs and 100
trials (including forced-choice trials) during
the concurrent FR 1 schedule of sucrose
reinforcement. The two groups of 6 rats
differed when histamine was introduced on
the preferred lever from the previous training
session. Six rats were assigned to the Short ITI
group with 5-s ITIs and 6 rats were assigned to
the Long ITI group with 120-s ITIs. All sessions
were capped at 60 min and both groups of rats
could complete a maximum of 28 trials per
session (including forced-choice trials). For
both groups, the sucrose + injection lever was
switched when there were at least two consec-
utive sessions with less than 30 percent of
Fig. 7. The percent responses on the sucrose + injection lever as a function ITI duration (s). In the panel showing
mean data, there are 8 values at the 6-s ITI, 12 values at the 30-s ITI, 6 values at the 60-s ITI, 3 values at the 90-s ITI, and 14
values at the 120-s ITI. * 5 significantly different from the 6-s ITI (p , .05).
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responses occurring on the sucrose + injection
lever or 15 consecutive sessions with no
systematic differences in responding across
the levers.
RESULTS
Figure 8 shows the number of sucrose +
injection responses, the number of sucrose-
alone responses, and the percent sucrose +
injection-lever responding for individual rats
in the Short ITI group. Responding increased
on the sucrose-alone lever across sessions while
responding on the sucrose + injection lever
tended to remain low throughout. The sucrose
+ injection lever was switched following four
(Br2) to nine (Br1) sessions across rats.
Following the lever switch, a similar pattern
of low responding on both levers occurred
followed by increased responding on the
sucrose-alone lever.
Figure 9 shows the number of sucrose +
injection responses, the number of sucrose-
alone responses, and the percent sucrose +
injection lever responding for individual rats
in the Long ITI group. As with rats in the
Short ITI group, responding generally in-
creased on the sucrose-alone lever relative to
responding on the sucrose + injection lever,
with the exception of Rat R2. The sucrose +
injection lever was switched between 7 (R6) to
Fig. 8. Short ITI group. Number of responses on the sucrose + injection (inj) lever, sucrose lever, and percent
responses on the injection lever across preliminary sucrose-pellet training (T), acquisition, and lever switch. Individual
panels show data of individual rats (Br1-Br6). Lever switches are indicated by ‘‘Sw.’’
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10 (R4) sessions for all rats except Rat R2. For
Rat R2, responding tended to decrease across
15 sessions but not enough to meet the criteria
for a lever change. Rat R5’s catheter failed
shortly following a lever switch. Following the
lever switch in the remaining rats, responding
occurred either nondifferentially (Rats R2 and
R3) or tended to persist on what was the
sucrose-alone lever in the previous condition
(Rats R1, R4, and R6). The ITI duration was
decreased to 5 s for Rats R3 and R6 and
responding on the sucrose + injection lever
decreased relative to the sucrose-alone lever
for both rats. These findings suggest that
performance improved with a decrease in ITI
duration, although a confound with additional
training precludes any definitive conclusions
based on this condition alone.
In both the Short and Long ITI groups,
histamine functioned as a punisher of re-
sponding during initial acquisition; however,
those effects differed between the groups
following a reversal of the contingencies.
Thus, histamine functioned as a punisher
during acquisition regardless of ITI duration
but only when the ITI was short following a
change in sucrose + injection lever.
DISCUSSION
Experiment 3 showed that histamine func-
tioned as a punisher when ITIs were short (i.e.,
5 s – 30 s) but not when ITIs were long (90 –
Fig. 9. Long ITI group. Number of responses on the sucrose + injection (inj) lever, sucrose lever, and percent
responses on the injection lever across preliminary sucrose-pellet training (T), acquisition, lever switch, and change in ITI
duration. Individual panels show data of individual rats (R1-R6). Lever switches are indicated by ‘‘Sw.’’
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120 s). The ITI duration and trials per session,
however, were confounded. Controlling for
this confound, the present experiment partial-
ly supported the findings from Experiment 3.
Although most rats in both the Short and
Long ITI groups responded less on the sucrose
+ injection lever during initial acquisition, only
responding by the Short ITI group switched
when the sucrose + injection lever was
changed. The findings from Experiment 4
suggest that the failure to acquire the punish-
ment effect with 120-s ITIs in Experiment 3
likely was a result of too few sessions in that
condition. However, failures to reverse perfor-
mance when the histamine lever was switched
with longer ITIs likely were at least partially a
function of the longer ITI durations.
Better performance, as defined by more
sucrose-alone lever responding, might be
expected with short ITIs under the conditions
of the present experiments. A leading expla-
nation for poorer performance with shorter
ITIs in operant conditional-discrimination
procedures is proactive interference (see
Grant, 1975). According to proactive interfer-
ence, performance on previous trials (n - 1, n -
2, etc.) interferes with performance on the
current trial (n). If a left response is reinforced
on one trial, for instance, there is a tendency
to choose left on subsequent trials regardless
of the stimulus configurations of those trials.
Given that consequences for responding on
both levers were identical from trial to trial
within conditions of the present experiment,
previous trials influencing responding on the
current trial could only improve performance
on subsequent trials (see Grant, 1975, 2000;
Roberts, 1980, for relevant findings). Thus,
increasing ‘‘interference’’ from one trial to
the next with shorter ITIs could only improve
performance in the present experiment, con-
sistent with the present findings.
In addition, shorter ITIs might improve
performance (i.e., decrease sucrose + injection
responding) by increasing accumulated hista-
mine from one trial to the next, thereby
increasing any aversive effects produced by
histamine. Prior to differential responding
across levers in the Short ITI group, an
accumulation of the aversive effects of hista-
mine might be indicated by the initial sup-
pression of responding on both levers only in
the Short ITI group. This effect was not readily
observed in the Long ITI group. Thus, the
effect of accumulated histamine initially might
have decreased the number of trials per
session with short ITIs but later enhanced
the ability of histamine to selectively decrease
responding on the sucrose + injection lever.
The effects of ITI duration on reversal
learning (e.g., lever switch) have been mixed
when rats and pigeons have been trained to
discriminate between a response producing
food and a different response producing no
food. Consistent with the present findings,
several researchers have found improved
reversal learning with shorter ITIs (e.g.,
Williams, 1971). Conversely, reversal-learning
performance and ITI duration also have been
shown to be positively related (Sarason,
Sarason, Miller, & Mahmoud, 1956) and
unrelated (North, 1950a, 1950b). Williams
has noted that, with some exceptions, differ-
ences in ITI duration systematically impact
reversal learning when ITIs are short (between
0 – 60 s) and responses on the nonreinforced
option asymptote beyond 60 s. The findings
from Experiment 3 (see Figure 7) and the
present experiment generally support Wil-
liams’s findings.
Finally, the fact that changes in ITI duration
impacted performance in the present proce-
dure suggests that altering other procedural
variables (e.g., FR value, open vs. closed
economy, histamine dose, etc.) could produce
different patterns of results. For instance,
changing the overall magnitude or quality of
reinforcement might affect sensitivity to the
punishing effects of intravenous histamine (cf.
Ferraro & Perkins, 1968). Another question of
interest is whether longer-acting histaminergic
or other aversive drugs might result in
improved reversal learning with longer ITIs.
GENERAL DISCUSSION
The present series of experiments found
that histamine functioned as a punisher of
operant behavior in a choice situation in rats.
Experiment 1 showed that 1.0 mg/kg/inj
histamine was a more reliable punisher than
vehicle and smaller histamine doses (0.1 and
0.3 mg/kg/inj). Experiment 2 showed that
daily changes in the histamine lever were too
frequent to produce reliable switching in
responding, even when responding reliably
changed following three-session conditions.
Finally, Experiments 3 and 4 showed stronger
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punishing effects of histamine with shorter ITI
durations.
The present findings support previous find-
ings that intravenous histamine is an effective
punisher of operant behavior in monkeys
(e.g., Goldberg, 1980; Negus, 2005; Woolver-
ton, 2003). We extended the findings of Negus
and Woolverton in showing that the punishing
effects of drugs can be studied in relatively
standard operant choice situations in rodents.
Thus, the present findings suggest that the
punishing effects of intravenous drugs in
rodents could be studied in any laboratory
equipped with standard self-administration
equipment. These findings open the way to
examining the aversive effects of drugs in
rodents in other situations such as in tradi-
tional free-operant concurrent variable-inter-
val (VI) schedules of reinforcement. Studying
punishment with drugs in free-operant proce-
dures would confer the advantage of generat-
ing a large amount of behavioral data (per-
haps with fewer drug injections) but this would
most likely be at the expense of such a rapid
assessment of drug effects. Nonetheless, the
ability to study aversive stimuli, including the
punishing effects of drugs in rodents, is
important given the disparity between the
prevalent use of aversive contingencies in
natural settings (e.g., physical and verbal
reprimands, timeout) and the need for studies
examining basic processes governing the
aversive effects of stimuli (Lerman & Vorn-
dran, 2002).
The punishing effects of intravenous hista-
mine in rodents have been demonstrated
previously, although the procedure was not a
standard operant procedure. Sharpless (1961)
arranged for intravenous injections of hista-
mine to be contingent on rats entering one
goal box of a T-maze when both goal boxes
were baited with food. As in the present
experiments, histamine was shown to punish
the response resulting in histamine injections.
Unlike the present data, however, a very large
dose of histamine (8.75 mg/kg/inj) was used.
Perhaps more important, it is unclear the
extent to which the runway paradigm reflects
Pavlovian conditioned approach responses
versus an operant response (see Farwell &
Ayres, 1979, and Boakes, 1979, for relevant
discussions). Bardo and Bevins (2000) re-
viewed a series of experiments in which
response-independent drug injections pro-
duced disparate behavioral and neurological
changes compared with when drugs were
presented response dependently. Similar ar-
guments might be extended to the use of
single-goal runway procedures that have been
used to assess the aversive effects of drugs, with
the anxiogenic effects of intravenous cocaine
in particular (see Ettenberg, 2009, for a
review).
Histamine injections always were presented
response dependently on one of two available
levers in the present experiments. In addition
to suppressing responses on the histamine-
contingent lever, responding on both levers
occasionally was suppressed. Bolles et al.
(1980) found similar effects under a number
of conditions. For instance, two response
topographies produced food on a single
manipulandum, but only one topography
resulted in shock. When shock was introduced
in the beginning of a session, both topogra-
phies were suppressed. By the end of a session,
the topography that was not shocked came to
predominate. Bolles et al. suggested that these
different patterns early and late in sessions
with shock reveal a change in learning from a
stimulus–stimulus association (i.e., lever–
shock) to a more refined response–stimulus
(i.e., topography–shock) association. Along
these lines, in the present experiments, sup-
pressed responding on both levers reflected
associations between the intelligence panel
and histamine injections (stimulus–stimulus
learning). Following more extended training,
rats learned that histamine injections were
specific to responding on one lever (response–
stimulus learning).
Experiment 4 extended the findings of
Bolles et al. (1980) by suggesting that learning
responses resulting in punishing stimuli is
dependent on previous experience and ITI
duration. Differential responding across levers
occurred during acquisition with long and
short ITIs, but reversal learning was evident
only when ITIs were short. Relevant to these
findings, Karsh (1970, 1971) directly assessed
reversal learning in choice situations with
shock punishment in rats. When one lever
produced food reinforcement and the other
lever produced no consequence (extinction)
in one group or extinction plus shock in
another group, responding in both groups
rapidly switched between those levers when
the contingencies were reversed. However, in
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another group, food was presented on one
lever and shock plus food were presented on
another lever. In this group, rats repeatedly
failed to respond more on the lever not
producing shock when shock alternated be-
tween levers across daily sessions (Karsh, 1970)
or multisession conditions (Karsh, 1971).
Across reversals, responding perseverated on
the original food-alone lever arranged during
acquisition, regardless of whether shock cur-
rently was contingent on that lever or the
other lever. The present findings and others
(Negus, 2005; Woolverton, 2003) suggest that
conflict situations (food + punishment) do not
necessarily result in perseverative behavior.
Moreover, the finding that reversal learning
was found when ITI durations were short but
perseverative responding was found when ITI
durations were long suggests the effects
reported by Karsh might be modulated by
procedural variables, including ITI duration.
Interestingly, Karsh used 60-s ITI durations,
which according to Williams (1971) is the ITI
duration at which reversal-learning perfor-
mance with food reinforcement begins to
degrade.
In light of the effect of ITI duration
modulating the punishing effects of intrave-
nous histamine, it is interesting to consider the
relation between the cardiovascular effects and
behavioral effects of histamine. Histamine
likely decreased blood pressure by dilating
small blood vessels causing a baroreceptor
reflex that increased heart rate (see Brown &
Roberts, 2001). Caution must be used when
comparing cardiovascular and behavioral ef-
fects because histamine was presented re-
sponse independently when assessing cardio-
vascular effects and response dependently
when assessing behavioral effects (see Bardo
& Bevins, 2000, for a related discussion of such
differences in rewarding drug effects). None-
theless, one potential relation between the
effects of histamine is that the cardiovascular
effects directly mediated the punishing effects.
Several points of evidence, however, suggest
that cardiovascular effects do not mediate the
punishing effects of histamine. First, despite
successful acquisition in Experiment 4 with
120-s ITIs, those rats failed to reverse their
performance when the histamine lever was
switched. Presumably, the lever switch did not
affect the duration and/or intensity of the
cardiovascular effects. Second, the 0.1 and
0.3 mg/kg/inj dose resulted in clear cardio-
vascular changes but did not always produce
clear punishing effects. Finally, Goldberg
(1980) found that the H2-receptor antagonist
cimetidine blocked cardiovascular effects of
histamine but not the punishing effects. The
punishing, but not cardiovascular, effects of
histamine were blocked by the H1-receptor
antagonist diphenhydramine. Together, these
findings suggest that the punishing effects
produced by intravenous histamine generally
do not depend on cardiovascular changes.
Unfortunately, the physiological mechanisms
producing the aversive effects of histamine in
Goldberg’s and the present experiments are
unknown. Some insight comes from studies of
human participants receiving intravenous in-
fusions of liberators of endogenous histamine
(e.g., Compound 48/80; see Brown & Roberts,
2001). These human participants reported
burning and itching sensations in the hands,
face, scalp, and ears, along with other feelings
of discomfort (e.g., colic, nausea). Similar
aversive effects resulting from histamine also
might occur in rats and potentially be the
source of the punishing effects observed in the
present experiment.
Given that cardiovascular effects likely do
not mediate the punishing effects of hista-
mine, the question remains as to what does
mediate the punishing effects of histamine.
Katz and Goldberg (1986) showed that a range
of H1-receptor antagonists attenuated the
punishing effects of histamine, but not the
punishing effects of shock (cf. Bergman &
Spealman, 1986). Conversely, Katz and Gold-
berg also showed that drugs that reduce
anxiety in humans (e.g., benzodiazepines)
attenuate the punishing effects of both shock
and histamine (see Cook & Davidson, 1973;
Kleven & Koek, 1999; Rowlett, Lelas, Tor-
natzky, & Licata, 2006, for relative potencies of
a range of benzodiazepines in humans and
laboratory animals). In addition, other re-
searchers have shown that anxiolytics reduce
the punishing effects of a range of other
intravenous drugs (e.g., nicotine, Goldberg &
Spealman, 1983; beta carboline, Takada et al.,
1992), as well as other forms of punishment
(e.g., signaled timeout, van Haaren & Ander-
son, 1997). Given the general finding that the
effects of punishing stimuli are attenuated
with anxiolytics, perhaps all punishing effects
of stimuli are mediated by the emotional,
HISTAMINE PUNISHMENT AND CHOICE 221
anxiety-producing effects of those stimuli. The
neuropsychopharmacological systems that me-
diate the emotional effects of punishing
stimuli are likely to differ among stimuli that
punish operant behavior. Regardless of the
substrate that mediates the process of punish-
ment, the findings from the present experi-
ments suggest that those effects can be
modulated by environmental context.
A future direction in this line of research is
to determine whether the present procedure
can be used to discriminate between drugs
producing true punishing effects and drugs
that are self-administered but at relatively low
levels. For instance, the dose of nicotine shown
to produce the highest levels of self-adminis-
tration (0.03 mg/kg/inj, free base) on FR 1
schedules of reinforcement in rats maintains
approximately 30 responses per 1-hr session
(Donny, Caggiula, Mielke, Jacobs, Rose, &
Sved, 1998). If similar levels of nicotine self-
administration were to be maintained with the
present choice procedure and the remaining
responses allocated to the sucrose-alone lever,
only approximately one third of total respons-
es would be allocated to the drug lever.
According to our definition of punishment
(i.e., fewer responses on the drug lever)
nicotine would have functioned as a punisher
under these circumstances. Therefore, the
present findings with histamine suggest this
choice procedure can effectively assess the
punishing effects of aversive drugs; however,
its validation for assessing reinforcing drug
effects remains a goal for future experiments.
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